Patent details

Basic Information

Publication number:

EP2773758

PCT Application Number:

US2012062894

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128067303

PCT Publication Number:

WO2013067076

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR USE IN NEUROPROTECTION

French Title of Invention:

COMPOSITIONS POUR LA NEUROPROTECTION

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR NEUROPROTEKTION

SPC Number:

Dates

Filing date:

01/11/2012

Grant date:

07/06/2017

EP Publication Date:

10/09/2014

PCT Publication Date:

10/05/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2017

EP B1 Publication Date:

07/06/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/11/2017

Expiration date:

01/11/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/06/2017

 

 

Name:

Quark Pharmaceuticals, Inc.

Address:

6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Inventor

Name:

FEINSTEIN, Elena

Address:

Israel (IL)

Priority

1

Priority Number:

201161554982 P

Priority Date:

03/11/2011

Priority Country:

United States (US)

2

Priority Number:

201261663627 P

Priority Date:

25/06/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/713; A61P 27/16; C12N 15/113;

Publication

European Patent Bulletin

Issue number:

201723

Publication date:

07/06/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2018	Outgoing Correspondence	1